L & S Advisors’s GE HealthCare GEHC Stock Holding History

L & S Advisors’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-33,858	Closed	-$3.08M	–	340
2024 Q1	$3.08M	Buy	+33,858	New	+$2.82M	0.35%	86

Other funds holding GEHC

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ECU

Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.65% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

L & S Advisors's GEHC Position: Q2 2024 in Review

L & S Advisors sold out of GE HealthCare (GEHC) in Q2 2024, closing a stake of 33,858 shares — an estimated $3.08M sold.

L & S Advisors first reported a position in GEHC in Q1 2024 and held it in 1 quarter. The position peaked at $3.08M in Q1 2024. 1,216 funds tracked by Wall St. Rank hold GEHC as of Q2 2024.

L & S Advisors reported no remaining GE HealthCare position as of Q2 2024 after selling out during the quarter.
L & S Advisors sold 33,858 GE HealthCare shares in Q2 2024, an estimated $3.08M.
L & S Advisors first reported a position in GE HealthCare in Q1 2024 and held it in 1 quarter.
L & S Advisors's GE HealthCare position peaked at $3.08M in Q1 2024.
1,216 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2024.

Based on L & S Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.